Adopting the TAPA cargo security standards in the pharmaceutical industry
Securing your supply chain
Diagnostics company offers reimbursement guidance along with genetic testing for cancer biomarkers
MolecularHealth's RxAssistance evaluates patient access to commercial therapeutics and clinical trials
Specialty pharmaceuticals demand integrated patient and prescriber approaches
True 'market access' should involve coordinated approaches to patients and their healthcare providers
Master data management (MDM) takes center stage
MDM practices are moving far beyond compliance concerns
Dedicated pharma facilities to open at Philadelphia and Bangalore airports
American Airlines and India's Menzies Aviation Bobba build cold chain capacity
Roche acquisition of InterMune highlights Big Pharma interest in rare diseases
$8.3-billion deal is Roche’s biggest since acquiring Genentech in 2009
IMS Health rolls out Nexxus Mobile Sales to bring localized business intelligence to reps' tablets
Cloud-based system is intended to focus reps' sales efforts more effectively
Cracks are appearing in CMS' drive to publish Physicians Sunshine Act data
Now, CMS will publish 66% of received data on Sept. 30
BDI Pharma is opening a new distribution center in Irving, TX
Company handles distribution of 'niche' blood, chemotherapy and specialty products
Rescheduling of hydrocodone combination products is set for Oct. 6
The widely prescribed products will have some supply chain hiccups
Ameritox, drug screening provider, expands into adherence testing for antipsychotics
Company's Ingenuity Health service monitors Seroquel XR, Abilify usage
Huron Consulting offers a new compliance-monitoring service for clinical trial data
TrialRx service analyzes and mitigates disclosure risks
FedEx's dispute with DoJ over illicit-drug delivery widens to include money laundering charges
Will federal legislation resolve ongoing DEA/drug-distributor conflicts?
Healthcare charity speeds supplies to Africa's Ebola virus outbreak
Meanwhile, a scramble to accelerate vaccine testing ramps up
Investor group calls on biotech manufacturers' boards to be more forthright on biosimilars
Absence of agreed-on FDA guidance keeps biosimilars off the US market even as their use grows abroad
Sonoco ThermoSafe survey finds growing reliance on 3PLs for cold chain
Three times as many manufacturers expect more 3PL use as expect less; 38% see no change
AMA and 110 other medical associations seek Sunshine Act delay
Postponement of public data for six months is justified by slow rollout of CMS rules, they say
Specialty pharmacy links with UPS for faster delivery to patients, clinics
MedVantx pursues manufacturers looking for alternative distribution channels
Catalent goes public in a successful IPO
Blackstone Group-owned CDMO nets over $800 million
PBM formulary exclusion lists continue to grow
Battlefield over drug pricing and availability continues to widen between plan managers and pharma
For pharma, it's getting harder and harder to follow the money
Outsourced contract-administration provider highlights growth in invoicing and financial stewardship burdens
CVS/pharmacy earns URAC accreditation for 'community pharmacy'
First to gain newly established program reviewing therapy management and chronic care
Big Pharma shuffles investments--and people--around the industry
Amped-up financial transactions continue to roil the industry as Amgen announces a big layoff
Vaccination experts struggle to raise medication practices of physicians and treatment programs
Vaccine working group tries to build consensus on temperature control and dispensing practices
PCI grows beyond contract packaging, acquires UK's Penn Pharma
Adds drug development services to its clinical, commercial packaging
Sandoz files for first FDA biosimilar approval under 351(k) biosimilarity rules
Biosimilar filgrastim is already broadly marketed outside the US
Next wave in gray-market US drug sales: pharmacy 'facilitators'
Rogue online pharmacies are going the brick-and-mortar route
GPhA: 'Abuse' of REMS programs costs drug payers $5.4 billion annually
Generics association ramps up criticism of brand owners' tactics to delay generic introductions
McKesson Specialty Health enters dedicated 3PL arena
US drug-wholesaling leader has 'never had a true 3PL offering'--but that changes now
